Genes2me LLP

Genes2me diagnostic test commercially available in India

Genes2me LLP CEO & Founder Neeraj Gupta sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.

Genes2me is an India-based high end diagnostic lab.

Quick facts: Genes2me LLP

Price: £0.00

Market Cap: £0.00


e-Therapeutics’ Barlow hails deals with Novo Nordisk and ‘top five pharma...

Ray Barlow, chief executive of e-Therapeutics (LON:ETX), talks to Proactive’s Andrew Scott about the company’s unique approach to drug discovery, which uses computational techniques to find potential breakthrough new treatments. He also provided some insight into recent tie-ups with Denmark’s...

4 days, 2 hours ago

2 min read